Acetyl- L-Carnitine RSS
Article Published Date: 2011 Dec 26
CONCLUSION: Data showed that administering Acetyl l--Carnitine may reduce both physical and mental fatigue in elderly and improves both the cognitive status and physical functions.
Acetyl-L-carnitine is effective in the treatment of early stages of Alzheimer's disease and vascular dementia.
CONCLUSION: Acetyl-L-carnitine (ALC) can be recommended in the abovementioned doses for treatment of early stages of Alzheimer’s disease and Vascular Dementia.
Acetyl-l-carnitine and R-alpha-lipoic acid partially reverses brain decay and RNA/DNA oxidation associated with memory loss in rats.
CONCLUSION: These results suggest that feeding ALCAR and LA to old rats improves performance on memory tasks by lowering oxidative damage and improving mitochondrial function.
Acetyl-l-carnitine delays the mitochondrial decay of aging and improves cognitive function in Alzheimers disease.
CONCLUSION: A recent meta--analysis of 21 double--blind clinical trials of acetyl carnitine in the treatment of mild cognitive impairment and mild Alzheimer's disease showed significant efficacy vs. placebo. A meta--analysis of 4 clinical trials of LA for treatment of neuropathic deficits in diabetes showed significant efficacy vs. placebo.
- Acetyl- L-Carnitine
- Alzheimer's disease
- anticipatory anxiety
- B Vitamins
- cognitive function
- Cognitive Impairment
- hepatic encephalopathy.
- Hericium erinaceum
- Lion's Mane mushroom
- occupational stress
- R-alpha-lipoic acid
- RNA/DNA oxidation
- vascular dementia
- vitamin B12
- vitamin B6